ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/24/2026
Back to search
Official data from USPTO
CLICKMER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CLICKMER
ST13
US500000097677631Class
1, 5, 42, 44
Filing
97677631
Registration
7459774
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
06/24/2026
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
11/15/2022
Registration date
07/30/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/30/2024
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
MANCHESTER, GB
Examiner
TWAY, TATIANA R
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
APIS ASSAY TECHNOLOGIES LTD.
Clickmer Systems GmbH
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparationsbiological preparations and biochemical preparations for industrial and scientific use; Biotechnological preparationscellsproteinsenzymespeptidescultures of microorganisms for industrial and scientific use; Chemical preparationsbiological preparationsbiochemical preparations and biotechnological preparationsdiagnostic preparations other than for medical or veterinary purposes; Chemical additives for use in the manufacture of pharmaceuticals; Chemicalbiologicalbiochemical and biotechnological products and preparations for use in the manufacturing of pharmaceuticalsDNA/RNA oligonucleotidesantibodiesnucleic acidsproteinslipidspolysaccharidesenzymespeptidesmicroorganismscell cultures and cells as well as fragmentsfractions and derivatives thereof
Class 5
Chemicalbiologicalbiochemicalbiotechnological and pharmaceutical products and preparationsDNA/RNA oligonucleotidesantibodiesnucleic acidsproteinslipidspolysaccharidesenzymespeptidesmicroorganismscell cultures and cells as well as fragmentsfractions and derivatives thereoffor medicalveterinary or pharmaceutical purposesfor the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination and immunostimmulation; therapeutic agents for medicalveterinary and pharmaceutical purposesfor the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination and immunostimmulationmedicaldiagnostic agents for medicalveterinary and pharmaceutical purposes; preparations for health caremedicinal preparations for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination and immunostimmulation; Medicines for for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination and immunostimmulationvaccines
Class 42
Scientific research and development for third partiesespecially in the fields of diagnosticspharmaceuticalschemistrybiologybiochemistry and biotechnology; scientific and technological servicesproviding medical research information and scientific research informationfeasibility studiestesting services and analysis services in the fields of diagnosticspharmaceuticalschemistrybiologybiochemistry and biotechnology; scientific laboratory and chemicalbiologicalbiochemicalbiotechnological and pharmaceutical analytical services
Class 44
Medical and veterinary services; medical and veterinary diagnostic serviceslaboratory services for diagnosis of diseases and genetic defects
Publications
History of USPTO decisions and trademark events.
27 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/15/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/30/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/12/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
12/13/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
12/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/15/2023
GNRT
NON-FINAL ACTION E-MAILED
09/15/2023
CNRT
NON-FINAL ACTION WRITTEN
09/15/2023
DOCK
ASSIGNED TO EXAMINER
08/29/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/23/2023
ALIE
ASSIGNED TO LIE
01/23/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/22/2022
NWAP
NEW APPLICATION ENTERED
11/18/2022
Continuous trademark protection
Get notified about every new filing that threatens CLICKMER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.